Mechanisms of interstrand DNA crosslink repair and human disorders

Genes and Environment

Volumn 38, Issue 1, 2016, Pages

  Hashimoto, Satoru ^a   Anai, Hirofumi ^a   Hanada, Katsuhiro ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Fanconi anemia; Homologous recombination; Nucleotide excision repair; Translesion DNA synthesis

Indexed keywords

DNA HELICASE; DOUBLE STRANDED DNA;

CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CHEMICAL STRUCTURE; DNA CROSS LINKING; DNA END JOINING REPAIR; DNA REPLICATION; DOUBLE STRANDED DNA BREAK; EXCISION REPAIR; GENE FUNCTION; GENE MUTATION; GENETIC DISORDER; GENOMIC INSTABILITY; HUMAN; INTERSTRAND DNA CROSSLINK; MISMATCH REPAIR; NONHUMAN; REVIEW; SACCHAROMYCES CEREVISIAE;

EID: 84973568810     PISSN: 18807046     EISSN: 18807062     Source Type: Journal    
DOI: 10.1186/s41021-016-0037-9     Document Type: Review

References (95)

1. Dronkert ML, Kanaar R. Repair of DNA interstrand cross-links. Mutat Res. 2001;486(4):217-47.
2. Guainazzi A, Scharer OD. Using synthetic DNA interstrand crosslinks to elucidate repair pathways and identify new therapeutic targets for cancer chemotherapy. Cell Mol Life Sci. 2010;67(21):3683-97. doi:10.1007/s00018-010-0492-6.
3. Legerski RJ Repair of DNA interstrand cross-links during S phase of the mammalian cell cycle. Environ Mol Mutagen. 2010;51(6):540-51. doi:10.1002/em.20566.
4. Clauson C, Scharer OD, Niedernhofer L. Advances in understanding the complex mechanisms of DNA interstrand cross-link repair. Cold Spring Harb Perspect Biol. 2013;5(10):a012732. doi:10.1101/cshperspect.a012732.
5. Liu X, Lao Y, Yang IY, Hecht SS, Moriya M. Replication-coupled repair of crotonaldehyde/acetaldehyde-induced guanine-guanine interstrand crosslinks and their mutagenicity. Biochemistry. 2006;45(42):12898-905. doi:10.1021/bi060792v.
6. Zhu G, Song L, Lippard SJ. Visualizing inhibition of nucleosome mobility and transcription by cisplatin-DNA interstrand crosslinks in live mammalian cells. Cancer Res. 2013;73(1):4451-60. doi:10.1158/0008-5472.CAN-13-0198.
7. Hanada K, Budzowska M, Modesti M, Maas A, Wyman C, Essers J, et al. The structure-specific endonuclease Mus81-Eme1 promotes conversion of interstrand DNA crosslinks into double-strands breaks. EMBO J. 2006;25(20):4921-32. doi:10.1038/sj.emboj.7601344.
8. Stern RS Psoralen and ultraviolet a light therapy for psoriasis. N Engl J Med. 2007;357(7):682-90. doi:10.1056/NEJMct072317.
9. Huang H, Zhu L, Reid BR, Drobny GP, Hopkins PB. Solution structure of a cisplatin-induced DNA interstrand cross-link. Science. 1995;270(5243):1842-5.
10. Rink SM, Hopkins PB. A mechlorethamine-induced DNA interstrand crosslink bends duplex DNA. Biochemistry. 1995;34(4):1439-45.
11. Gilman A. The initial clinical trial of nitrogen mustard. Am J Surg. 1963;105: 574-8.
12. McHugh PJ, Sones WR, Hartley JA. Repair of intermediate structures produced at DNA interstrand cross-links in Saccharomyces cerevisiae. Mol Cell Biol. 2000;20(10):3425-33.
13. Mutzhas MF, Holzle E, Hofmann C, Plewig G. A new apparatus with high radiation energy between 320-460 nm: physical description and dermatological applications. J Invest Dermatol. 1981;76(1):42-7.
14. Haran TE, Crothers DM. Phased psoralen cross-links do not bend the DNA double helix. Biochemistry. 1988;27(18):6967-71.
15. Hwang GS, Kim JK, Choi BS. The solution structure of a psoralen cross-linked DNA duplex by NMR and relaxation matrix refinement. Biochem Biophys Res Commun. 1996;219(1):191-7. doi:10.1006/bbrc.1996.0204.
16. Norman D, Live D, Sastry M, Lipman R, Hingerty BE, Tomasz M, et al. NMR and computational characterization of mitomycin cross-linked to adjacent deoxyguanosines in the minor groove of the d(T-A-C-G-T-A).d(T-A-C-G-T-A) duplex. Biochemistry. 1990;29(11):2861-75.
17. Rink SM, Lipman R, Alley SC, Hopkins PB, Tomasz M. Bending of DNA by the mitomycin C-induced, GpG intrastrand cross-link. Chem Res Toxicol. 1996; 9(2):382-9. doi:10.1021/tx950156q.
18. McHugh PJ, Spanswick VJ, Hartley JA. Repair of DNA interstrand crosslinks: molecular mechanisms and clinical relevance. Lancet Oncol. 2001;2(8):483-90. doi:10.1016/S1470-2045(01)00454-5.
19. Sarkar S, Davies AA, Ulrich HD, McHugh PJ. DNA interstrand crosslink repair during G1 involves nucleotide excision repair and DNA polymerase zeta. EMBO J. 2006;25(6):1285-94. doi:10.1038/sj.emboj.7600993.
20. Wood RD Mammalian nucleotide excision repair proteins and interstrand crosslink repair. Environ Mol Mutagen. 2010;51(6):520-6. doi:10.1002/em.20569.
21. McHugh PJ, Sarkar S. DNA interstrand cross-link repair in the cell cycle: a critical role for polymerase zeta in G1 phase. Cell Cycle. 2006;5(10):1044-7.
22. Williams HL, Gottesman ME, Gautier J. Replication-independent repair of DNA interstrand crosslinks. Mol Cell. 2012;47(1):140-7. doi:10.1016/j.molcel.2012.05.001.
23. Klug AR, Harbut MB, Lloyd RS, Minko IG. Replication bypass of N2-N2 deoxyguanosine interstrand cross-links by human DNA polymerases eta and iota. Chem Res Toxicol. 2012;25(3):755-62. doi:10.1021/tx300011w.
24. Minko IG, Harbut MB, Kozekov ID, Kozekova A, Jakobs PM, Olson SB, et al. Role for DNA polymerase kappa in the processing of N2-N2-guanine interstrand cross-links. J Biol Chem. 2008;283(25):17075-82. doi:10.1074/jbc. M801238200.
25. De Silva IU, McHugh PJ, Clingen PH, Hartley JA. Defining the roles of nucleotide excision repair and recombination in the repair of DNA interstrand cross-links in mammalian cells. Mol Cell Biol. 2000;20(21): 7980-90.
26. Niedernhofer LJ, Odijk H, Budzowska M, van Drunen E, Maas A, Theil AF, et al. The structure-specific endonuclease Ercc1-Xpf is required to resolve DNA interstrand cross-link-induced double-strand breaks. Mol Cell Biol. 2004; 24(13):5776-87. doi:10.1128/MCB.24.13.5776-5787.2004.
27. De Silva IU, McHugh PJ, Clingen PH, Hartley JA. Defects in interstrand cross-link uncoupling do not account for the extreme sensitivity of ERCC1 and XPF cells to cisplatin. Nucleic Acids Res. 2002;30(17):3848-56.
28. Enzlin JH, Scharer OD. The active site of the DNA repair endonuclease XPF-ERCC1 forms a highly conserved nuclease motif. EMBO J. 2002;21(8):2045-53. doi:10.1093/emboj/21.8.2045.
29. Abraham J, Lemmers B, Hande MP, Moynahan ME, Chahwan C, Ciccia A, et al. Eme1 is involved in DNA damage processing and maintenance of genomic stability in mammalian cells. EMBO J. 2003;22(22):6137-47. doi:10. 1093/emboj/cdg580.
30. Chen XB, Melchionna R, Denis CM, Gaillard PH, Blasina A, Van de Weyer I, et al. Human Mus81-associated endonuclease cleaves Holliday junctions in vitro. Mol Cell. 2001;8(5):1117-27.
31. Rothfuss A, Grompe M. Repair kinetics of genomic interstrand DNA cross-links: evidence for DNA double-strand break-dependent activation of the Fanconi anemia/BRCA pathway. Mol Cell Biol. 2004;24(1):123-34.
32. Takata M, Sasaki MS, Tachiiri S, Fukushima T, Sonoda E, Schild D, et al. Chromosome instability and defective recombinational repair in knockout mutants of the five Rad51 paralogs. Mol Cell Biol. 2001;21(8):2858-66. doi:10. 1128/MCB.21.8.2858-2866.2001.
33. Kraakman-van der Zwet M, Overkamp WJ, van Lange RE, Essers J, van Duijn-Goedhart A, Wiggers I, et al. Brca2 (XRCC11) deficiency results in radioresistant DNA synthesis and a higher frequency of spontaneous deletions. Mol Cell Biol. 2002;22(2):669-79.
34. Wesoly J, Agarwal S, Sigurdsson S, Bussen W, Van Komen S, Qin J, et al. Differential contributions of mammalian Rad54 paralogs to recombination, DNA damage repair, and meiosis. Mol Cell Biol. 2006;26(3):976-89. doi:10. 1128/MCB.26.3.976-989.2006.
35. Petermann E, Helleday T. Pathways of mammalian replication fork restart. Nat Rev Mol Cell Biol. 2010;11(10):683-7. doi:10.1038/nrm2974.
36. Bakker ST, de Winter JP, te Riele H. Learning from a paradox: recent insights into Fanconi anaemia through studying mouse models. Dis Model Mech. 2013;6(1):40-7. doi:10.1242/dmm.009795.
37. Vermeij WP, Hoeijmakers JH, Pothof J. Aging: not all DNA damage is equal. Curr Opin Genet Dev. 2014;26:124-30. doi:10.1016/j.gde.2014.06.006.
38. Taniguchi T, D'Andrea AD. Molecular pathogenesis of Fanconi anemia: recent progress. Blood. 2006;107(11):4223-33. doi:10.1182/blood-2005-10-4240.
39. Wilson DB, Link DC, Mason PJ, Bessler M. Inherited bone marrow failure syndromes in adolescents and young adults. Ann Med. 2014;46(6):353-63. doi:10.3109/07853890.2014.915579.
40. Hira A, Yoshida K, Sato K, Okuno Y, Shiraishi Y, Chiba K, et al. Mutations in the gene encoding the E2 conjugating enzyme UBE2T cause Fanconi anemia. Am J Hum Genet. 2015;96(6):1001-7. doi:10.1016/j.ajhg.2015.04.022.
41. Hoeijmakers JH DNA damage, aging, and cancer. N Engl J Med. 2009; 361(15):1475-85. doi:10.1056/NEJMra0804615.
42. Laugel V. Cockayne syndrome: the expanding clinical and mutational spectrum. Mech Ageing Dev. 2013;134(5-6):161-70. doi:10.1016/j.mad.2013.02.006.
43. Hashimoto S, Egly JM. Trichothiodystrophy view from the molecular basis of DNA repair/transcription factor TFIIH. Hum Mol Genet. 2009;18(R2):R224-30. doi:10.1093/hmg/ddp390.
44. Sepe S, Payan-Gomez C, Milanese C, Hoeijmakers JH, Mastroberardino PG. Nucleotide excision repair in chronic neurodegenerative diseases. DNA Repair (Amst). 2013;12(8):568-77. doi:10.1016/j.dnarep.2013.04.009.
45. Garaycoechea JI, Crossan GP, Langevin F, Daly M, Arends MJ, Patel KJ. Genotoxic consequences of endogenous aldehydes on mouse haematopoietic stem cell function. Nature. 2012;489(7417):571-5. doi:10.1038/nature11368.
46. Zhang J, Walter JC. Mechanism and regulation of incisions during DNA interstrand cross-link repair. DNA Repair (Amst). 2014;19:135-42. doi:10.1016/j.dnarep.2014.03.018.
47. Nishimura K, Ishiai M, Horikawa K, Fukagawa T, Takata M, Takisawa H, et al. Mcm8 and Mcm9 form a complex that functions in homologous recombination repair induced by DNA interstrand crosslinks. Mol Cell. 2012;47(4):511-22. doi:10.1016/j. molcel.2012.05.047.
48. Raschle M, Knipscheer P, Enoiu M, Angelov T, Sun J, Griffith JD, et al. Mechanism of replication-coupled DNA interstrand crosslink repair. Cell. 2008; 134(6):969-80. doi:10.1016/j.cell.2008.08.030.
49. Knipscheer P, Raschle M, Smogorzewska A, Enoiu M, Ho TV, Scharer OD, et al. The Fanconi anemia pathway promotes replication-dependent DNA interstrand cross-link repair. Science. 2009;326(5960):1698-701. doi:10.1126/science.1182372.
50. Long DT, Raschle M, Joukov V, Walter JC. Mechanism of RAD51-dependent DNA interstrand cross-link repair. Science. 2011;333(6038):84-7. doi:10.1126/science.1204258.
51. Budzowska M, Graham TG, Sobeck A, Waga S, Walter JC. Regulation of the Rev1-pol zeta complex during bypass of a DNA interstrand cross-link. EMBO J. 2015;34(14):1971-85. doi:10.15252/embj.201490878.
52. Tian Y, Paramasivam M, Ghosal G, Chen D, Shen X, Huang Y, et al. UHRF1 Contributes to DNA damage repair as a lesion recognition factor and nuclease scaffold. Cell Rep. 2015;10(12):1957-66. doi:10.1016/j.celrep.2015.03.038.
53. Liang CC, Zhan B, Yoshikawa Y, Haas W, Gygi SP, Cohn MA. UHRF1 Is a sensor for DNA interstrand crosslinks and recruits FANCD2 to initiate the Fanconi Anemia pathway. Cell Rep. 2015;10(12):1947-56. doi:10.1016/j.celrep.2015.02.053.
54. Liu X, Gao Q, Li P, Zhao Q, Zhang J, Li J, et al. UHRF1 targets DNMT1 for DNA methylation through cooperative binding of hemi-methylated DNA and methylated H3K9. Nat Commun. 2013;4:1563. doi:10.1038/ncomms2562.
55. Nishiyama A, Yamaguchi L, Sharif J, Johmura Y, Kawamura T, Nakanishi K, et al. Uhrf1-dependent H3K23 ubiquitylation couples maintenance DNA methylation and replication. Nature. 2013;502(7470):249-53. doi:10.1038/nature12488.
56. Muto M, Kanari Y, Kubo E, Takabe T, Kurihara T, Fujimori A, et al. Targeted disruption of Np95 gene renders murine embryonic stem cells hypersensitive to DNA damaging agents and DNA replication blocks. J Biol Chem. 2002;277(37):34549-55. doi:10.1074/jbc.M205189200.
57. Tachibana A, Kato T, Ejima Y, Yamada T, Shimizu T, Yang L, et al. The FANCA gene in Japanese Fanconi anemia: reports of eight novel mutations and analysis of sequence variability. Hum Mutat. 1999;13(3):237-44. doi:10.1002/(SICI)1098-1004(1999)13:3<237::AID-HUMU8>3.0.CO;2-F.
58. Fei P, Yin J, Wang W. New advances in the DNA damage response network of Fanconi anemia and BRCA proteins. FAAP95 replaces BRCA2 as the true FANCB protein. Cell Cycle. 2005;4(1):80-6.
59. Strathdee CA, Gavish H, Shannon WR, Buchwald M. Cloning of cDNAs for Fanconi's anaemia by functional complementation. Nature. 1992;356(6372):763-7. doi:10.1038/356763a0.
60. Howlett NG, Taniguchi T, Olson S, Cox B, Waisfisz Q, De Die-Smulders C, et al. Biallelic inactivation of BRCA2 in Fanconi anemia. Science. 2002; 297(5581):606-9. doi:10.1126/science.1073834.
61. Timmers C, Taniguchi T, Hejna J, Reifsteck C, Lucas L, Bruun D, et al. Positional cloning of a novel Fanconi anemia gene, FANCD2. Mol Cell. 2001;7(2):241-8.
62. Waisfisz Q, Saar K, Morgan NV, Altay C, Leegwater PA, de Winter JP, et al. The Fanconi anemia group E gene, FANCE, maps to chromosome 6p. Am J Hum Genet. 1999;64(5):1400-5. doi:10.1086/302385.
63. de Winter JP, Leveille F, van Berkel CG, Rooimans MA, van Der Weel L, Steltenpool J, et al. Isolation of a cDNA representing the Fanconi anemia complementation group E gene. Am J Hum Genet. 2000;67(5):1306-8. doi:10.1016/S0002-9297(07)62959-0.
64. de Winter JP, Rooimans MA, van Der Weel L, van Berkel CG, Alon N, Bosnoyan-Collins L, et al. The Fanconi anaemia gene FANCF encodes a novel protein with homology to ROM. Nat Genet. 2000;24(1):15-6. doi:10.1038/71626.
65. de Winter JP, Waisfisz Q, Rooimans MA, van Berkel CG, Bosnoyan-Collins L, Alon N, et al. The Fanconi anaemia group G gene FANCG is identical with XRCC9. Nat Genet. 1998;20(3):281-3. doi:10.1038/3093.
66. Smogorzewska A, Matsuoka S, Vinciguerra P, McDonald 3rd ER, Hurov KE, Luo J, et al. Identification of the FANCI protein, a monoubiquitinated FANCD2 paralog required for DNA repair. Cell. 2007;129(2):289-301. doi:10.1016/j.cell.2007.03.009.
67. Dorsman JC, Levitus M, Rockx D, Rooimans MA, Oostra AB, Haitjema A, et al. Identification of the Fanconi anemia complementation group I gene. FANCI Cell Oncol. 2007;29(3):211-8.
68. Levitus M, Waisfisz Q, Godthelp BC, de Vries Y, Hussain S, Wiegant WW, et al. The DNA helicase BRIP1 is defective in Fanconi anemia complementation group. J Nat Genet. 2005;37(9):934-5. doi:10.1038/ng1625.
69. Litman R, Peng M, Jin Z, Zhang F, Zhang J, Powell S, et al. BACH1 is critical for homologous recombination and appears to be the Fanconi anemia gene product FANCJ. Cancer Cell. 2005;8(3):255-65. doi:10.1016/j.ccr.2005.08.004.
70. Meetei AR, Yan Z, Wang W. FANCL replaces BRCA1 as the likely ubiquitin ligase responsible for FANCD2 monoubiquitination. Cell Cycle. 2004;3(2):179-81.
71. Rahman N, Seal S, Thompson D, Kelly P, Renwick A, Elliott A, et al. PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nat Genet. 2007;39(2):165-7. doi:10.1038/ng1959.
72. Reid S, Schindler D, Hanenberg H, Barker K, Hanks S, Kalb R, et al. Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer. Nat Genet. 2007;39(2):162-4. doi:10.1038/ng1947.
73. Vaz F, Hanenberg H, Schuster B, Barker K, Wiek C, Erven V, et al. Mutation of the RAD51C gene in a Fanconi anemia-like disorder. Nat Genet. 2010;42(5):406-9. doi:10.1038/ng.570.
74. Meindl A, Hellebrand H, Wiek C, Erven V, Wappenschmidt B, Niederacher D, et al. Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene. Nat Genet. 2010;42(5):410-4. doi:10.1038/ng.569.
75. Kim Y, Lach FP, Desetty R, Hanenberg H, Auerbach AD, Smogorzewska A. Mutations of the SLX4 gene in Fanconi anemia. Nat Genet. 2011;43(2):142-6. doi:10.1038/ng.750.
76. Thompson LH, Brookman KW, Weber CA, Salazar EP, Reardon JT, Sancar A, et al. Molecular cloning of the human nucleotide-excision-repair gene ERCC4. Proc Natl Acad Sci U S A. 1994;91(15):6855-9.
77. Niedernhofer LJ, Garinis GA, Raams A, Lalai AS, Robinson AR, Appeldoorn E, et al. A new progeroid syndrome reveals that genotoxic stress suppresses the somatotroph axis. Nature. 2006;444(7122):1038-43. doi:10.1038/nature05456.
78. Osorio A, Bogliolo M, Fernandez V, Barroso A, de la Hoya M, Caldes T, et al. Evaluation of rare variants in the new fanconi anemia gene ERCC4 (FANCQ) as familial breast/ovarian cancer susceptibility alleles. Hum Mutat. 2013; 34(12):1615-8. doi:10.1002/humu.22438.
79. Sawyer SL, Tian L, Kahkonen M, Schwartzentruber J, Kircher M. University of Washington Centre for Mendelian G et al. Biallelic mutations in BRCA1 cause a new Fanconi anemia subtype. Cancer Discov. 2015;5(2):135-42. doi:10.1158/2159-8290.CD-14-1156.
80. Rickman KA, Lach FP, Abhyankar A, Donovan FX, Sanborn EM, Kennedy JA, et al. Deficiency of UBE2T, the E2 Ubiquitin Ligase necessary for FANCD2 and FANCI Ubiquitination, causes FA-T subtype of Fanconi anemia. Cell Rep. 2015;12(1):35-41. doi:10.1016/j.celrep.2015.06.014.
81. Jaspers NG, Raams A, Silengo MC, Wijgers N, Niedernhofer LJ, Robinson AR, et al. First reported patient with human ERCC1 deficiency has cerebro-oculo-facio-skeletal syndrome with a mild defect in nucleotide excision repair and severe developmental failure. Am J Hum Genet. 2007;80(3):457-66. doi:10.1086/512486.
82. Tanaka K, Miura N, Satokata I, Miyamoto I, Yoshida MC, Satoh Y, et al. Analysis of a human DNA excision repair gene involved in group A xeroderma pigmentosum and containing a zinc-finger domain. Nature. 1990;348(6296):73-6. doi:10.1038/348073a0.
83. Koken MH, Vreeken C, Bol SA, Cheng NC, Jaspers-Dekker I, Hoeijmakers JH, et al. Cloning and characterization of the Drosophila homolog of the xeroderma pigmentosum complementation-group B correcting gene, ERCC3. Nucleic Acids Res. 1992;20(21):5541-8.
84. Weeda G, Eveno E, Donker I, Vermeulen W, Chevallier-Lagente O, Taieb A, et al. A mutation in the XPB/ERCC3 DNA repair transcription gene, associated with trichothiodystrophy. Am J Hum Genet. 1997;60(2):320-9.
85. Oh KS, Khan SG, Jaspers NG, Raams A, Ueda T, Lehmann A, et al. Phenotypic heterogeneity in the XPB DNA helicase gene (ERCC3): xeroderma pigmentosum without and with Cockayne syndrome. Hum Mutat. 2006; 27(11):1092-103. doi:10.1002/humu.20392.
86. Legerski R, Peterson C. Expression cloning of a human DNA repair gene involved in xeroderma pigmentosum group C. Nature. 1992;359(6390):70-3. doi:10.1038/359070a0.
87. Arrand JE, Bone NM, Johnson RT. Molecular cloning and characterization of a mammalian excision repair gene that partially restores UV resistance to xeroderma pigmentosum complementation group D cells. Proc Natl Acad Sci U S A. 1989;86(18):6997-7001.
88. Broughton BC, Steingrimsdottir H, Weber CA, Lehmann AR. Mutations in the xeroderma pigmentosum group D DNA repair/transcription gene in patients with trichothiodystrophy. Nat Genet. 1994;7(2):189-94. doi:10.1038/ng0694-189.
89. van Hoffen A, Kalle WH, de Jong-Versteeg. A, Lehmann AR, van Zeeland AA, Mullenders LH. Cells from XP-D and XP-D-CS patients exhibit equally inefficient repair of UV-induced damage in transcribed genes but different capacity to recover UV-inhibited transcription. Nucleic Acids Res. 1999; 27(14):2898-904.
90. Chu G, Chang E. Xeroderma pigmentosum group E cells lack a nuclear factor that binds to damaged DNA. Science. 1988;242(4878):564-7.
91. Vermeulen W, Jaeken J, Jaspers NG, Bootsma D, Hoeijmakers JH. Xeroderma pigmentosum complementation group G associated with Cockayne syndrome. Am J Hum Genet. 1993;53(1):185-92.
92. Nouspikel T, Clarkson SG. Mutations that disable the DNA repair gene XPG in a xeroderma pigmentosum group G patient. Hum Mol Genet. 1994;3(6):963-7.
93. Henning KA, Li L, Iyer N, McDaniel LD, Reagan MS, Legerski R, et al. The Cockayne syndrome group A gene encodes a WD repeat protein that interacts with CSB protein and a subunit of RNA polymerase II TFIIH. Cell. 1995;82(4):555-64.
94. Troelstra C, van Gool A, de Wit J, Vermeulen W, Bootsma D, Hoeijmakers JH. ERCC6, a member of a subfamily of putative helicases, is involved in Cockayne's syndrome and preferential repair of active genes. Cell. 1992; 71(6):939-53.
95. Coin F, Proietti De Santis L, Nardo T, Zlobinskaya O, Stefanini M, Egly JM. p8/TTD-A as a repair-specific TFIIH subunit. Mol Cell. 2006;21(2):215-26. doi:10.1016/j.molcel.2005.10.024.